In their quest to understand how cancers take root, grow and spread, scientists have for the past half-century explored the ...

Deep within the cellular landscape, a quiet failure was taking place, impeding a potentially successful form of cancer ...

Zhong-Yin Zhang leads a team that has developed and validated a novel series of small-molecule inhibitors that promote ...

REDWOOD CITY, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ: CHRS), today announced that the company will be participating in upcoming investor conferences: Baird 2026 ...

Accelerating Pipeline 2.0 Execution And Sustained Global Commercial Momentum. CS2009 Achieved Key Clinical Validations for Efficacy and Safety As of August 2026, updated data further confirmed the fa ...

InxMed Co., Ltd ('InxMed'), a clinical-stage biotechnology company dedicated to developing innovative therapies targeting ...

Chronic respiratory diseases substantially magnify pneumococcal pneumonia and invasive disease risk, with especially high CAP ...

A HER3-DXd and olaparib combination enhanced DNA damage, apoptosis, and antitumor immune activity in preclinical NSCLC models.

FDA clears IND for ADI-212, an off-the-shelf PSMA-targeted gamma-delta CAR T for metastatic castration-resistant prostate ...

Preclinical manuscript that characterizes the mechanism of action, broad antitumor efficacy, and immune-activating properties ...

Researchers in Purdue University's College of Pharmacy have developed and validated a novel series of small-molecule ...